Approval · Notice of Compliance 29090 · 2022
NEXAVAR: Notice of Compliance 29090
Issued September 28, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29090
- Date
- September 28, 2022
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Convert the Product Monograph to the 2020 format. Add Blister Packaging format in the Product Monograph. Add Mock-up labels for blister and carton labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NEXAVAR | Not yet assigned | — |
Medicinal ingredients
- SORAFENIB 200 MG per TAB